ctrl K

AI Score

Unlock

Day One Biopharmaceutical... (DAWN)

AI Score

Unlock

8.19

0.07 (0.86%)

At close: Mar 27, 2025, 3:59 PM

8.18

-0.02%

After-hours: Mar 27, 2025, 05:36 PM EDT

Day One Biopharmaceuticals Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	131.16M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	5.28M	383K	531K	199K	155K	n/a
Gross Profit	125.88M	-383K	-531K	-199K	-155K	n/a
Operating Income	-217.27M	-206.06M	-146.91M	-72.74M	-13.78M	-14.9M
Interest Income	n/a	17.19M	4.75M	4K	30.00	2.08K
Pretax Income	-88.35M	-188.92M	-142.18M	-72.75M	-43.84M	-16.98M
Net Income	-95.5M	-188.92M	-132.18M	-70.44M	-40.51M	-14.71M
Selling & General & Admin	115.45M	75.54M	61.29M	29.16M	4.68M	1.01M
Research & Development	227.7M	130.52M	85.62M	43.58M	9.1M	13.9M
Other Expenses	n/a	1.00	-18K	-15K	-31K	-2K
Operating Expenses	343.15M	206.06M	146.91M	72.74M	13.78M	14.9M
Interest Expense	n/a	n/a	4.75M	4K	30K	2.08M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	348.43M	206.06M	146.91M	72.74M	13.78M	14.9M
Income Tax	-7.14M	n/a	-10.01M	-2.31M	-3.34M	-2.27M
Shares Outstanding (Basic)	93.62M	79.77M	65.47M	61.95M	61.93M	61.93M
Shares Outstanding (Diluted)	93.62M	79.77M	65.47M	61.95M	61.93M	61.93M
EPS (Basic)	-1.02	-2.37	-2.02	-1.14	-0.65	-0.24
EPS (Diluted)	-1.02	-2.37	-2.02	-1.14	-0.65	-0.24
EBITDA	-217.27M	-206.06M	-141.65M	-72.56M	-43.66M	-2K
Depreciation & Amortization	n/a	383K	531K	199K	155K	14.9M